Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults

Clinical trial NCT07518589 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07518589
Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Evaluate the Safety and Tolerability Healthy and Overweight or Obese Participants

Start date: 2026-04-02
Primary completion: 2027-11-24
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.